Lyra cuts 75% of staff, looks to sublease Waltham, Watertown facilities
By Hannah Green After a trial of Lyra Therapeutics Inc.’s drug to treat sinus inflammation failed to meet the goals of a late-stage trial earlier this month, the company is cutting its workforce and looking to sublease its facilities as it hunts for “strategic options.” Lyra (Nasdaq: LYRA) shared in a Tuesday securities filing that it’s laying off 75% of […]